Document Type

Article

Publication Date

4-24-2018

Comments

This article has been peer reviewed. It is the author’s final published version in Radiology Case Reports, Volume 13, Issue 3, April 2018, Pages 713-718.

The published version is available at https://doi.org/10.1016/j.radcr.2018.04.001 . Copyright © Gummadi et al.

Abstract

The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization. While monitoring for tumor response after transarterial chemoembolization is crucial, current imaging strategies are suboptimal. The standard of care is contrast-enhanced magnetic resonance imaging or computed tomography imaging performed at least 4 to 6 weeks after therapy. We present a case in which contrast-enhanced ultrasound identified a specific extra-hepatic collateral from the gastroduodenal artery supplying residual viable tumor and assisting with directed transarterial management.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Language

English

Included in

Radiology Commons

Share

COinS